Home / Treatments / Tirzepatide
Weight LossTirzepatide
A once-weekly dual GIP/GLP-1 for stronger appetite control and metabolic support.
- Acts on two appetite and metabolic pathways
- Strong appetite control
- Dose increased gradually by your provider
$299/moor $199/mo on a 6-month planGet started →
- Format
- Once-weekly subcutaneous injection
- Labs
- Recommended: Metabolic Baseline
- Evidence
- Well studied
- Includes
- Provider review, compounded medication from a licensed 503A pharmacy, free discreet shipping, 24/7 care team
How it works
Tirzepatide activates two hormone receptors, GIP and GLP-1, that help regulate appetite, blood sugar, and how your body handles food.
Important safety information
Common side effects are gastrointestinal: nausea, diarrhea, constipation, or reduced appetite. Not appropriate for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, or who is pregnant or planning pregnancy. Your provider reviews your full history before prescribing.
Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. Program disclaimers
